An Observational Clinical Study on the Construction of an Artificial Neural Network Model for ICU Pneumonia
1 other identifier
observational
600
1 country
1
Brief Summary
To achieve rapid, intelligent and accurate microbiological diagnosis and treatment for ICU pneumonia, an artificial neural network model for microbiological diagnosis is established, which depends on many clinical cases and machine deep learning from clinical experts' judgements according to species-specific rapid detection of pathogenic bacteria and other clinical parameter variables of patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 5, 2024
CompletedFirst Posted
Study publicly available on registry
October 28, 2024
CompletedStudy Start
First participant enrolled
January 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
October 28, 2024
August 1, 2024
2.9 years
September 5, 2024
October 24, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
clinical evaluation of each microbial detected whether in colonization or infection
Two experienced senior physicians are organized to determine whether the microbial are colonized or infected according to clinical values.
day1,day3 and day7 after enrollment
Interventions
to establish an artificial neural network model for pathogen diagnosis in ICU pneumonia
Eligibility Criteria
Pneumonia patients who admitted to Nanjing Drum Tower Hospital from Jan 1,2025 to Dec 31,2027 and meet the inclusion criteria.
You may qualify if:
- aged ≥18 years;
- agreed to obtain lower respiratory specimens for rapid testing of pathogenic bacteria;
- all were enrolled by an experienced physician who dynamically determined that the microorganisms were in a colonised or infected state;
- signed an informed consent form.
You may not qualify if:
- pregnant women;
- lactating women;
- patients who could not obtain lower respiratory specimens;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, 210008, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yan Wang, Master
Nanjing Drum Tower Hosptial
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 5, 2024
First Posted
October 28, 2024
Study Start
January 1, 2025
Primary Completion (Estimated)
December 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
October 28, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share